Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Mapping Cancer Through Cell Surface Sugars
Oncology Biochemistry and molecular biology Microscopy and imaging Research and Innovations

Mapping Cancer Through Cell Surface Sugars

New imaging approach identifies distinct glycan signatures in tumors, immune cells, and healthy tissue

06/01/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Clinical Scorecard: Mapping Cancer Through Cell Surface Sugars

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationIndividuals with cancer
Care Setting

Key Highlights

  • Development of a microscopy-based method called 'glycan atlassing'
  • Ability to map glycan distribution at nanometer-scale resolution
  • Distinct glycan patterns observed in normal vs. transformed breast epithelial cells
  • Rapid glycan reorganization detected in immune cells post-activation

Guideline-Based Recommendations

Diagnosis

  • Utilize glycan organization patterns for tumor classification

Management

    Monitoring & Follow-up

    • Monitor changes in glycan organization during immune responses

    Risks

    • Current limitations include need for specialized imaging and labor-intensive analysis

    Patient & Prescribing Data

    Patients with breast cancer

    Clinical Best Practices

    • Incorporate glycan mapping in research settings to enhance understanding of cancer biology
    • Utilize super-resolution microscopy for detailed glycan analysis

    Related Resources & Content

    • Nature Nanotechnology

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

    Newsletters

    Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

    Newsletter Signup Image

    Explore More in Pathology

    Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

    False

    Advertisement

    Recommended

    False

    Related Content

    Intense Intestines
    Microscopy and imaging
    Intense Intestines

    January 19, 2024

    1 min read

    Some powerful fluorescent microscopy in this Image of the Month…

    Context Matters in Cancer Biology
    Microscopy and imaging
    Context Matters in Cancer Biology

    December 27, 2021

    1 min read

    Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

    When Pathology Goes 3D
    Microscopy and imaging
    When Pathology Goes 3D

    February 2, 2022

    1 min read

    Stratifying cancers with non-destructive 3D pathology

    Sacrificing Safety for Speed?
    Microscopy and imaging
    Sacrificing Safety for Speed?

    February 4, 2022

    3 min read

    Wide adaptation of antigen testing could increase the risk of exposure to infectious SARS-CoV-2 samples

    Affiliations:

    Specialties:

    Areas of Expertise:

    Contributions:

    False

    The Pathologist
    Subscribe

    About

    • About Us
    • Work at Conexiant Europe
    • Terms and Conditions
    • Privacy Policy
    • Advertise With Us
    • Contact Us

    Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.